Integrated Quantitative Investments LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 2046834
BELLEVUE, WA
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,433,432
New position
Shares Held
8,505
first reported quarter
Ownership
0.008%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#353
of 772 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 19%
Shared 0%
None 81%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Integrated Quantitative Investments LLC holds $10,389,461 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
61,555 | $2,525,601 | |
| 2 | LQDA |
Liquidia Corp
|
31,620 | $2,521,062 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
48,037 | $1,738,939 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
8,505 | $1,433,432 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
37,396 | $1,174,234 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
93,689 | $394,430 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
38,501 | $322,638 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
|
19,079 | $279,125 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,433,432 | 8,505 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||